SGMT: Sagimet Biosciences Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 125.10
Enterprise Value ($M) 49.96
Book Value ($M) 91.06
Book Value / Share 2.85
Price / Book 1.37
NCAV ($M) 90.99
NCAV / Share 2.85
Price / NCAV 1.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -1.02
Return on Equity (ROE) -1.27

Liquidity (mrq)
Quick Ratio 17.09
Current Ratio 17.09

Balance Sheet (mrq) ($M)
Current Assets 96.65
Assets 96.72
Liabilities 5.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.00
Operating Income -30.74
Net Income -27.88

Cash Flow Statement (mra) ($M)
Cash From Operations -23.77
Cash from Investing 12.58
Cash from Financing 86.17

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-11 13G/A Fmr Llc 2.44 -61.38
02-14 13G Hillhouse Capital Management, Ltd. 6.80
02-14 13G Kpcb Pandemic & Bio Defense Fund Llc 6.30
02-14 13G Baker Bros. Advisors Lp 6.80
02-14 13G New Enterprise Associates 13 Lp 6.60
02-05 13G Point72 Asset Management, L.P. 5.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-21 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 76,546 86,565 88.43
2024-04-25 70,655 67,899 104.06
2024-04-24 75,926 68,297 111.17
2024-04-23 65,392 156,124 41.88

(click for more detail)

Similar Companies
RYTM – Rhythm Pharmaceuticals, Inc. SAGE – Sage Therapeutics, Inc.
SCYX – SCYNEXIS, Inc. SIGA – SIGA Technologies, Inc.
SKYE – Skye Bioscience, Inc.


Financial data and stock pages provided by
Fintel.io